Jun 18, 2021 07:54 PM (GMT+8) · EqualOcean
Yesterday, Yonghe medical, a hair transplant institution, submitted a prospectus to the Hong Kong stock exchange, with Morgan Stanley and CICC as co sponsors. If successful, Yonghe medical will become "the first share of hair transplant". According to the prospectus, the operating revenue of Yonghe from 2018 to 2020 will be 934 million, 1.22 billion and 1.64 billion respectively, with a compound annual growth rate of 32.4%. During the same period, the gross profit of Yonghe medical was 702 million, 889 million and 1222 million respectively, and the gross profit rate was 75.1%, 72.6% and 74.6% respectively. According to the data released by the China Association for health promotion and education, there are nearly 250 million Chinese people suffering from hair loss, with an average of one in six people losing their hair. The hair loss population is mainly between 20 and 40 years old, and the development is the fastest around 30 years old, 20 years ahead of the previous generation.

This text is a result of machine translation.